Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate.

Jitrangsri, Kritamorn; Khaing, Ei Mon; Intaraphairot, Torsak; Phaechamud, Thawatchai; Mahadlek, Jongjan

Jitrangsri, Kritamorn; Khaing, Ei Mon; Intaraphairot, Torsak; Phaechamud, Thawatchai; Mahadlek, Jongjan.

Afiliación

Jitrangsri K; Department of Chemical Engineering and Pharmaceutical Chemistry, School of Engineering and Technology, Walailak University, Nakhon Srithammarat 80160, Thailand.
Khaing EM; Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM Group), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Intaraphairot T; Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM Group), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Phaechamud T; Program of Pharmaceutical Engineering, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Mahadlek J; Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM Group), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.

Gels ; 9(9)2023 Sep 12.

Article en En | MEDLINE | ID: mdl-37754418

Palabras clave

cytotoxicity; gamboge; gambogic acid; imatinib mesylate; in situ gel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Gels Año: 2023 Tipo del documento: Article País de afiliación: Tailandia